Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 243681, 7 pages
http://dx.doi.org/10.1155/2015/243681
Research Article

Adenocarcinoma with BAC Features Presented as the Nonsolid Nodule Is Prone to Be False-Negative on 18F-FDG PET/CT

NanFang PET/CT Center, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou, Guangdong 510515, China

Received 8 September 2014; Revised 9 January 2015; Accepted 12 January 2015

Academic Editor: Ignasi Carrio

Copyright © 2015 Hu-bing Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. D. Travis, K. Garg, W. A. Franklin et al., “Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma,” Journal of Clinical Oncology, vol. 23, no. 14, pp. 3279–3287, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. W. L. Read, N. C. Page, R. M. Tierney, J. F. Piccirillo, and R. Govindan, “The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER database,” Lung Cancer, vol. 45, no. 2, pp. 137–142, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Arenberg, “Bronchioloalveolar carcinoma,” Seminars in Respiratory and Critical Care Medicine, vol. 32, no. 1, pp. 52–61, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Gaeta, A. Blandino, S. Pergolizzi et al., “Patterns of recurrence of bronchioloalveolar cell carcinoma after surgical resection: a radiological, histological, and immunohistochemical study,” Lung Cancer, vol. 42, no. 3, pp. 319–326, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Y. Lee, K. S. Lee, J. Han et al., “Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons,” Lung Cancer, vol. 65, no. 2, pp. 170–175, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. H. AL-Jahdali, A. N. Khan, S. Loutfi, and A. S. Al-Harbi, “Guidelines for the role of FDG-PET/CT in lung cancer management,” Journal of Infection and Public Health, vol. 5, supplement 1, pp. S35–S40, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Ambrosini, S. Nicolini, P. Caroli et al., “PET/CT imaging in different types of lung cancer: an overview,” European Journal of Radiology, vol. 81, no. 5, pp. 988–1001, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Y. Lee and K. S. Lee, “Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications,” Journal of Thoracic Imaging, vol. 26, no. 2, pp. 106–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. T.-W. Huang, L.-F. Lin, C.-M. Hsieh et al., “Positron emission tomography in bronchioloalveolar carcinoma of the lung,” European Journal of Surgical Oncology, vol. 38, no. 12, pp. 1156–1160, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Suzawa, M. Ito, S. Qiao et al., “Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size,” Lung Cancer, vol. 72, no. 2, pp. 191–198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Delbeke, R. E. Coleman, M. J. Guiberteau et al., “Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0,” Journal of Nuclear Medicine, vol. 47, no. 5, pp. 885–895, 2006. View at Google Scholar · View at Scopus
  12. T. J. Kim, C. M. Park, J. M. Goo, and K. W. Lee, “Is there a role for FDG PET in the management of lung cancer manifesting predominantly as ground-glass opacity?” The American Journal of Roentgenology, vol. 198, no. 1, pp. 83–88, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. J. Erasmus and H. A. MacApinlac, “Low-sensitivity FDG-PET studies: less common lung neoplasms,” Seminars in Nuclear Medicine, vol. 42, no. 4, pp. 255–260, 2012. View at Google Scholar · View at Scopus
  14. S. L. Aquino, E. F. Halpern, L. B. Kuester, and A. J. Fischman, “FDG-PET and CT features of non-small cell lung cancer based on tumor type,” International Journal of Molecular Medicine, vol. 19, no. 3, pp. 495–499, 2007. View at Google Scholar · View at Scopus
  15. J. S. Sun, K. J. Park, S. S. Sheen et al., “Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung cancers,” Lung Cancer, vol. 66, no. 2, pp. 205–210, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. A. H. Khandani, K. D. Whitney, S. M. Keller, C. R. Isasi, and M. Donald Blaufox, “Sensitivity of FDG PET, GLUT1 expression and proliferative index in bronchioloalveolar lung cancer,” Nuclear Medicine Communications, vol. 28, no. 3, pp. 173–177, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. L. E. Heyneman and E. F. Patz Jr., “PET imaging in patients with bronchioloalveolar cell carcinoma,” Lung Cancer, vol. 38, no. 3, pp. 261–266, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Nomori, K. Watanabe, T. Ohtsuka, T. Naruke, K. Suemasu, and K. Uno, “Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images,” Lung Cancer, vol. 45, no. 1, pp. 19–27, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Goudarzi, H. A. Jacene, and R. L. Wahl, “Diagnosis and differentiation of bronchioloalveolar carcinoma from adenocarcinoma with bronchioloalveolar components with metabolic and anatomic characteristics using PET/CT,” Journal of Nuclear Medicine, vol. 49, no. 10, pp. 1585–1592, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Kushihashi, H. Munechika, K. Ri et al., “Bronchioloalveolar adenoma of the lung: CT-pathologic correlation,” Radiology, vol. 193, no. 3, pp. 789–793, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Y. Lee, J. Han, K. S. Lee et al., “Lung adenocarcinoma as a solitary pulmonary nodule: prognostic determinants of CT, PET, and histopathologic findings,” Lung Cancer, vol. 66, no. 3, pp. 379–385, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Liu, H. Cheng, S. Yao et al., “The clinical application value of PET/CT in adenocarcinoma with bronchioloalveolar carcinoma features,” Annals of Nuclear Medicine, vol. 24, no. 7, pp. 541–547, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Tsunezuka, Y. Shimizu, N. Tanaka, T. Takayanagi, and M. Kawano, “Positron emission tomography in relation to Noguchi's classification for diagnosis of peripheral non-small-cell lung cancer 2 cm or less in size,” World Journal of Surgery, vol. 31, no. 2, pp. 314–317, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Iwano, S. Ito, K. Tsuchiya, K. Kato, and S. Naganawa, “What causes false-negative PET findings for solid-type lung cancer?” Lung Cancer, vol. 79, no. 2, pp. 132–136, 2013. View at Publisher · View at Google Scholar · View at Scopus